Insiders · Profile

Boyle Kevin S. Sr.

Chief Executive Officer at Alaunos Therapeutics. Filing since 16 Nov 2021. CIK 0001880600

Company
Date
Role
Action
Shares
Amount
Of holding
1 Sep 2023
Chief Executive Officer
Sold on a plan
68,014
$9.54K
7.9%
17 Nov 2021
Chief Executive Officer
Bought
9,116
$12.76K
1.0%
16 Nov 2021
Chief Executive Officer
Bought
884
$1.24K
0.1%
3 decisions on file.